NCT05776173
- Conditions
- β-thalassemia Major
- Locations
-
- Shanghai Ruijin Hospital Shanghai, China
Clinical trial condition
β-thalassemia Major
Explore clinical trials studying β-thalassemia Major. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
β-thalassemia Major trial results
Not Yet Recruiting
A Phase 2 Safety and Efficacy Study Evaluating CS-101 in Participants With β-Thalassemia Major
NCT07489196
- Conditions
- β-thalassemia Major
- Locations
-
- The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
- Children's Hospital of Fudan University Shanghai, Shanghai Municipality, China
- Ruijin Hospital Shanghai JiaoTong University School of Medicine Shanghai, Shanghai Municipality, China
NCT01745120
- Conditions
- Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
- Locations
-
- Los Angeles, California, United States
- Oakland, California, United States
- Chicago, Illinois, United States
- Philadelphia, Pennsylvania, United States
NCT00390858
- Conditions
- Iron Metabolism Disorders, Iron Overload, Metabolic Diseases, +4 more
- Locations
-
- Novartis Investigative Site Lyon, France
- Novartis Investigative Site Cagliari, Italy
- Novartis Investigative Site Genova, Italy
- Novartis Investigative Site Torino, Italy
Active, Not Recruiting
A Real-World Study of β-Thalassemia Major Treatment With Luspatercept in Taiwan
NCT06596642
- Conditions
- β-thalassemia Major
- Locations
-
- Local Institution - 02 Kaohsiung City, Taiwan
- Local Institution - 04 Tainan, Taiwan
- Local Institution - 01 Taipei, Taiwan
- Local Institution - 03 Taipei, Taiwan